Ledger.Open graph →

SEC Form D · Amendment · filed August 27, 2020

Adaptive Phage Therapeutics, Inc

Offering

$3.6M

Sold

—

Exemption

Rule 506(c)

Industry

Pharmaceuticals

Location

GAITHERSBURG, MD

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (11)

Gregory L. Merril · Gaithersburg, MDExec · Director Carl L. Merril · Gaithersburg, MDExec · Director Raymond L. Martz · Gaithersburg, MDDirector Ashley Granata · Los Angeles, CADirector Maren Steinberg · DENVER, COExec · Director Thomas Spicer · Luxembourg, LuxembourgExec · Director Subhendu L. Basu · Gaithersburg, MDExec Guillermo Guefen · Houston, TXExec · Director Nick P. Steinsberger · Tulsa, OKExec · Director Robert Ziehl · Portland, ORDirector Subhendu L. Basu · Gaithersburg, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗